View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
HHS/CMS | RIN: 0938-AT09 | Publication ID: Fall 2017 |
Title: Covered Outpatient Drug; Finalization of Line Extension Definition and Delay in Including U.S. Territories in the Definitions of States and United States (CMS-2345-F2) | |
Abstract:
This final rule responds to comments on the definition and identification of line extension drugs for which we requested comments in the Covered Outpatient Drug final rule with comment published on February 1, 2016. This rule also finalizes the interim final rule with comment period published on November 15, 2016 that delayed the inclusion of the territories in the definitions of States and United States until April 1, 2020. |
|
Agency: Department of Health and Human Services(HHS) | Priority: Substantive, Nonsignificant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Final Rule Stage |
Major: No | Unfunded Mandates: No |
EO 13771 Designation: Not subject to, not significant | |
CFR Citation: 42 CFR 447 | |
Legal Authority: Pub. L. 111-148 |
Legal Deadline:
None |
|||||||||||||||
Timetable:
|
Regulatory Flexibility Analysis Required: No | Government Levels Affected: State |
Federalism: No | |
Included in the Regulatory Plan: No | |
RIN Data Printed in the FR: No | |
Related RINs: Related to 0938-AQ41 | |
Agency Contact: Wendy Tuttle Health Insurance Specialist Department of Health and Human Services Centers for Medicare & Medicaid Services S1-01-16, Center for Medicaid and CHIP Services, MS: S2-14-26, 7500 Security Boulevard, Baltimore, MD 21244 Phone:410 786-8690 Email: wendy.tuttle@cms.hhs.gov |